PPG Sleep Apnea Detection

Sleep apnea affects an estimated 1 billion people worldwide, with the majority undiagnosed. PPG-based wearables can screen for it by tracking nocturnal oxygen desaturation and pulse rate variability, but the accuracy gap between a smartwatch and a clinical sleep study remains significant. This article explains what PPG can and cannot detect, and when a proper polysomnogram is still necessary.

How PPG Relates to Sleep Apnea

Obstructive sleep apnea (OSA) causes repeated pauses in breathing during sleep. Each apneic or hypopneic event has several consequences that are measurable with PPG:

Oxygen desaturation: When breathing stops, blood oxygen saturation (SpO2) drops. A typical moderate apneic event causes SpO2 to fall 4% or more before the person partially wakes and breathing resumes. Infrared PPG can estimate SpO2 via pulse oximetry.

Pulse rate changes: Each arousal from an apneic event triggers a sympathetic nervous system response that accelerates the heart rate transiently. This creates a characteristic oscillatory pulse rate variability pattern during sleep that correlates with apnea severity.

Pulse waveform morphology changes: Apneic events also produce characteristic changes in PPG waveform shape, including reduced amplitude (from vasoconstriction) and altered dicrotic notch appearance, due to increased sympathetic tone.

Respiratory effort signals: PPG amplitude modulation correlates with respiratory effort because intrathoracic pressure changes during breathing affect venous return and thus pulse amplitude. This creates a low-frequency oscillation in PPG amplitude that can be used to estimate respiratory rate and detect effort-independent breathing cessation.

PPG-Based Sleep Apnea Detection Methods

Oxygen Desaturation Index (ODI)

The simplest and most validated approach uses continuous SpO2 monitoring to compute the oxygen desaturation index: the number of times per hour SpO2 drops 3% or 4% from baseline. ODI correlates moderately with the apnea-hypopnea index (AHI) from polysomnography.

A systematic review by Rashid et al. (2021, doi:10.1002/lary.28663) of 8 studies (1,924 patients) found that ODI sensitivity ranged from 32% to 98.5% and specificity from 47.7% to 98% against AHI, with significant heterogeneity across studies. For a 4% ODI of ≥15 events/hour, specificity ranged from 75% to 98%.

The limitation: ODI misses many hypopneas that cause arousals without significant desaturation. In REM-related OSA and in patients with high baseline SpO2 reserve (such as younger patients), desaturation may not occur even during genuine apneic events.

Pulse Rate Variability Analysis

Pulse rate variability during sleep shows characteristic patterns in OSA that differ from normal sleep. The autonomic nervous system cycles through arousal-recovery sequences that produce low-frequency PRV oscillations with a period matching the apnea cycle (typically 20–60 seconds).

Algorithms that analyze very-low-frequency PRV components can detect these patterns. The 0.01–0.05 Hz band corresponds to cycle lengths of 20 to 100 seconds, which matches the repeating apnea-arousal cycle rather than individual breaths (normal breathing sits at roughly 0.15–0.4 Hz). Combining PRV-based detection with SpO2 monitoring is expected to perform better than either alone.

PPG Waveform Amplitude Variation

Respiratory-related amplitude modulation in the PPG waveform can be used to estimate respiratory rate during sleep. Sustained periods of absent respiratory signal, combined with concurrent pulse rate acceleration, are characteristic of obstructive events.

This approach is sensitive to signal quality and is difficult to implement reliably on consumer devices. Consumer sleep-apnea screening features do not share one sensor strategy: some use oximetry, while Apple's cleared feature uses accelerometer-derived breathing disturbances.

Consumer Wearable Performance

Apple Watch Sleep Apnea Detection

Apple received FDA clearance in September 2024 for sleep apnea notifications on supported Apple Watch models. The feature uses the accelerometer to detect small wrist movements associated with breathing disturbances. It analyzes breathing-disturbance data over 30-day evaluation periods and does not use the Blood Oxygen app.

In the validation study summarized for FDA clearance (K240929; 1,499 participants, with a type 3 home sleep apnea test as the reference), the feature showed 66.3% sensitivity and 98.5% specificity for moderate-to-severe sleep apnea (AHI ≥15). The high specificity means few false positives, but the sensitivity means about a third of people with moderate-to-severe OSA will not be flagged.

Withings ScanWatch

The Withings ScanWatch received CE mark in Europe as a medical device for sleep apnea screening. It combines continuous SpO2 monitoring with breathing-disturbance analysis; check the manufacturer's regulatory documentation for current validation figures. For how it stacks up as an everyday watch, see Withings ScanWatch vs Apple Watch.

Fitbit

Fitbit's Estimated Oxygen Variation (EOV) feature tracks SpO2 variation during sleep and provides a score indicating likely breathing disruption. The feature has not been validated as a medical device but shows qualitative correlation with AHI in observational data. Fitbit's formal validation work remains less published than Apple or Withings.

Ring-Form Devices

Finger-worn PPG devices (Oura Ring, Movano Ring) have better signal quality than wrist-worn devices because the finger has higher perfusion and the sensor sits closer to the arterial pulsation. Oura published internal validation data showing their third-generation ring achieved better SpO2 accuracy than wrist devices, though published peer-reviewed sleep apnea sensitivity/specificity data is limited.

For the published validation numbers side by side, with the cohort, reference test, and caveats behind each one, see the sleep apnea leaderboard.